Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
Background and aims Subjects with congenital chloride diarrhea (CLD; a defect in solute carrier family 26 member 3 (SLC26A3)) are prone to inflammatory bowel disease (IBD). We investigated fecal microbiota in CLD and CLD-associated IBD. We also tested whether microbiota is modulated by supplementation with the short-chain fatty acid butyrate. Subjects and methods We recruited 30 patients with CLD for an observational 3-week follow-up study. Thereafter, 16 consented to oral butyrate substitution for a 3-week observational period. Fecal samples, collected once a week, were assayed for calprotectin and potential markers of inflammation, and studied by 16S ribosomal ribonucleic acid (rRNA) gene amplicon sequencing and compared to that of 19 healthy controls and 43 controls with Crohn’s disease. Data on intestinal symptoms, diet and quality of life were collected. Results Patients with CLD had increased abundances of Proteobacteria, Veillonella, and Prevotella, and lower abundances of normally dominant taxa Ruminococcaceae and Lachnospiraceae when compared with healthy controls and Crohn´s disease. No major differences in fecal microbiota were found between CLD and CLD-associated IBD (including two with yet untreated IBD). Butyrate was poorly tolerated and showed no major effects on fecal microbiota or biomarkers in CLD. Conclusions Fecal microbiota in CLD is different from that of healthy subjects or Crohn´s disease. Unexpectedly, no changes in the microbiota or fecal markers characterized CLD-associated IBD, an entity with high frequency among patients with CLD.
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article/Letter to editor biblioteca |
Language: | English |
Subjects: | Life Science, |
Online Access: | https://research.wur.nl/en/publications/fecal-microbiota-in-congenital-chloride-diarrhea-and-inflammatory |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-wur-nl-wurpubs-598760 |
---|---|
record_format |
koha |
spelling |
dig-wur-nl-wurpubs-5987602025-01-14 Wedenoja, Satu Saarikivi, Aki Mälkönen, Jani Leskinen, Saara Lehto, Markku Adeshara, Krishna Tuokkola, Jetta Nikkonen, Anne Merras-Salmio, Laura Höyhtyä, Miikka Hörkkö, Sohvi Haaramo, Anu Salonen, Anne de Vos, Willem M. Korpela, Katri Kolho, Kaija Leena Article/Letter to editor PLoS ONE 17 (2022) 6 June ISSN: 1932-6203 Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease 2022 Background and aims Subjects with congenital chloride diarrhea (CLD; a defect in solute carrier family 26 member 3 (SLC26A3)) are prone to inflammatory bowel disease (IBD). We investigated fecal microbiota in CLD and CLD-associated IBD. We also tested whether microbiota is modulated by supplementation with the short-chain fatty acid butyrate. Subjects and methods We recruited 30 patients with CLD for an observational 3-week follow-up study. Thereafter, 16 consented to oral butyrate substitution for a 3-week observational period. Fecal samples, collected once a week, were assayed for calprotectin and potential markers of inflammation, and studied by 16S ribosomal ribonucleic acid (rRNA) gene amplicon sequencing and compared to that of 19 healthy controls and 43 controls with Crohn’s disease. Data on intestinal symptoms, diet and quality of life were collected. Results Patients with CLD had increased abundances of Proteobacteria, Veillonella, and Prevotella, and lower abundances of normally dominant taxa Ruminococcaceae and Lachnospiraceae when compared with healthy controls and Crohn´s disease. No major differences in fecal microbiota were found between CLD and CLD-associated IBD (including two with yet untreated IBD). Butyrate was poorly tolerated and showed no major effects on fecal microbiota or biomarkers in CLD. Conclusions Fecal microbiota in CLD is different from that of healthy subjects or Crohn´s disease. Unexpectedly, no changes in the microbiota or fecal markers characterized CLD-associated IBD, an entity with high frequency among patients with CLD. en application/pdf https://research.wur.nl/en/publications/fecal-microbiota-in-congenital-chloride-diarrhea-and-inflammatory 10.1371/journal.pone.0269561 https://edepot.wur.nl/572216 Life Science https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research |
institution |
WUR NL |
collection |
DSpace |
country |
Países bajos |
countrycode |
NL |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-wur-nl |
tag |
biblioteca |
region |
Europa del Oeste |
libraryname |
WUR Library Netherlands |
language |
English |
topic |
Life Science Life Science |
spellingShingle |
Life Science Life Science Wedenoja, Satu Saarikivi, Aki Mälkönen, Jani Leskinen, Saara Lehto, Markku Adeshara, Krishna Tuokkola, Jetta Nikkonen, Anne Merras-Salmio, Laura Höyhtyä, Miikka Hörkkö, Sohvi Haaramo, Anu Salonen, Anne de Vos, Willem M. Korpela, Katri Kolho, Kaija Leena Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease |
description |
Background and aims Subjects with congenital chloride diarrhea (CLD; a defect in solute carrier family 26 member 3 (SLC26A3)) are prone to inflammatory bowel disease (IBD). We investigated fecal microbiota in CLD and CLD-associated IBD. We also tested whether microbiota is modulated by supplementation with the short-chain fatty acid butyrate. Subjects and methods We recruited 30 patients with CLD for an observational 3-week follow-up study. Thereafter, 16 consented to oral butyrate substitution for a 3-week observational period. Fecal samples, collected once a week, were assayed for calprotectin and potential markers of inflammation, and studied by 16S ribosomal ribonucleic acid (rRNA) gene amplicon sequencing and compared to that of 19 healthy controls and 43 controls with Crohn’s disease. Data on intestinal symptoms, diet and quality of life were collected. Results Patients with CLD had increased abundances of Proteobacteria, Veillonella, and Prevotella, and lower abundances of normally dominant taxa Ruminococcaceae and Lachnospiraceae when compared with healthy controls and Crohn´s disease. No major differences in fecal microbiota were found between CLD and CLD-associated IBD (including two with yet untreated IBD). Butyrate was poorly tolerated and showed no major effects on fecal microbiota or biomarkers in CLD. Conclusions Fecal microbiota in CLD is different from that of healthy subjects or Crohn´s disease. Unexpectedly, no changes in the microbiota or fecal markers characterized CLD-associated IBD, an entity with high frequency among patients with CLD. |
format |
Article/Letter to editor |
topic_facet |
Life Science |
author |
Wedenoja, Satu Saarikivi, Aki Mälkönen, Jani Leskinen, Saara Lehto, Markku Adeshara, Krishna Tuokkola, Jetta Nikkonen, Anne Merras-Salmio, Laura Höyhtyä, Miikka Hörkkö, Sohvi Haaramo, Anu Salonen, Anne de Vos, Willem M. Korpela, Katri Kolho, Kaija Leena |
author_facet |
Wedenoja, Satu Saarikivi, Aki Mälkönen, Jani Leskinen, Saara Lehto, Markku Adeshara, Krishna Tuokkola, Jetta Nikkonen, Anne Merras-Salmio, Laura Höyhtyä, Miikka Hörkkö, Sohvi Haaramo, Anu Salonen, Anne de Vos, Willem M. Korpela, Katri Kolho, Kaija Leena |
author_sort |
Wedenoja, Satu |
title |
Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease |
title_short |
Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease |
title_full |
Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease |
title_fullStr |
Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease |
title_full_unstemmed |
Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease |
title_sort |
fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease |
url |
https://research.wur.nl/en/publications/fecal-microbiota-in-congenital-chloride-diarrhea-and-inflammatory |
work_keys_str_mv |
AT wedenojasatu fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT saarikiviaki fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT malkonenjani fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT leskinensaara fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT lehtomarkku fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT adesharakrishna fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT tuokkolajetta fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT nikkonenanne fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT merrassalmiolaura fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT hoyhtyamiikka fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT horkkosohvi fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT haaramoanu fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT salonenanne fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT devoswillemm fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT korpelakatri fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease AT kolhokaijaleena fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease |
_version_ |
1822265369416433664 |